Playing for his life: Double lung transplant patient who is now waiting for a new bowel live streams his 24-hour
Continue reading »Home ยป
First investigational drug therapy for liver disease NASH awaiting FDA approval
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently
Continue reading »